Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib.
about
Applications of PET imaging with the proliferation marker [18F]-FLTRetrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trialPrognostic impact of initial maximum standardized uptake value of (18)F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib.New strategy for monitoring targeted therapy: molecular imaging.PET/CT in therapy evaluation of patients with lung cancer.FLT PET-CT in evaluation of treatment response.The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors.PET Imaging-Based Phenotyping as a Predictive Biomarker of Response to Tyrosine Kinase Inhibitor Therapy in Non-small Cell Lung Cancer: Are We There Yet?Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak.The developing role of FDG PET imaging for prognostication and radiotherapy target volume delineation in non-small cell lung cancer
P2860
Q28083952-83C82F27-C057-4C47-8D06-6E8B14FA6051Q35244168-E26BF130-C5EA-4C03-BC8D-D882F6F9528DQ36399028-4916645E-5F88-4FFF-BC4E-05D7B774A65BQ37225316-3E9E2C0C-81C3-4FF6-B78D-7591086010D6Q38202189-385A2A09-4F71-483B-AAD1-C573B266D4D9Q38206772-BC5AA6F7-012D-4AAF-AD86-4AA61E36604DQ45215365-790C2010-CC27-47C0-8619-5216ADCD20C9Q50326521-7123B5CD-F26C-41A9-B405-87D37F7EDCEDQ53063872-A676D476-760C-471F-B04B-60548C1769C9Q57172944-9D6BF513-5260-4A72-84B0-1042A71FC30E
P2860
Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prognostic impact of [18F]fluo ...... ted first-line with erlotinib.
@ast
Prognostic impact of [18F]fluo ...... ted first-line with erlotinib.
@en
Prognostic impact of [18F]fluo ...... ted first-line with erlotinib.
@nl
type
label
Prognostic impact of [18F]fluo ...... ted first-line with erlotinib.
@ast
Prognostic impact of [18F]fluo ...... ted first-line with erlotinib.
@en
Prognostic impact of [18F]fluo ...... ted first-line with erlotinib.
@nl
prefLabel
Prognostic impact of [18F]fluo ...... ted first-line with erlotinib.
@ast
Prognostic impact of [18F]fluo ...... ted first-line with erlotinib.
@en
Prognostic impact of [18F]fluo ...... ted first-line with erlotinib.
@nl
P2093
P2860
P50
P1433
P1476
Prognostic impact of [18F]fluo ...... ated first-line with erlotinib
@en
P2093
Carsten Kobe
Deniz Kahraman
Erich Stoelben
Irini Papachristou
Jürgen Wolf
Lucia Nogova
Markus Dietlein
Reinhard Büttner
Silvia Querings
Thomas Zander
P2860
P304
P356
10.1371/JOURNAL.PONE.0053081
P407
P577
2013-01-04T00:00:00Z